Metropolitan Life Insurance CO Vbi Vaccines Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jun 20, 2023	BUY	$0.66 - $1.81 $8,675 - $23,792	13,145 New	13,145 $10,000
Q1 2022 Jun 20, 2023	BUY	$1.27 - $2.47 $16,694 - $32,468	13,145 New	13,145 $21,000
Q1 2022 Mar 30, 2023	SELL	$1.27 - $2.47 $26,771 - $52,067	-21,080 Reduced 61.59%	13,145 $21,000
Q1 2022 May 12, 2022	SELL	$1.27 - $2.47 $26,771 - $52,067	-21,080 Reduced 61.59%	13,145 $22,000
Q4 2021 Jun 21, 2023	BUY	$2.21 - $3.22 $75,637 - $110,204	34,225 New	34,225 $80,000
Q4 2021 Mar 30, 2023	SELL	$2.21 - $3.22 $6,367 - $9,276	-2,881 Reduced 7.76%	34,225 $80,000
Q4 2021 Feb 15, 2022	SELL	$2.21 - $3.22 $6,367 - $9,276	-2,881 Reduced 7.76%	34,225 $80,000
Q3 2021 Jun 21, 2023	BUY	$2.8 - $3.72 $103,896 - $138,034	37,106 New	37,106 $115,000
Q3 2021 Mar 30, 2023	SELL	$2.8 - $3.72 $54,191 - $71,996	-19,354 Reduced 34.28%	37,106 $115,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $54,191 - $71,996	-19,354 Reduced 34.28%	37,106 $115,000
Q2 2021 Jun 21, 2023	BUY	$2.61 - $4.17 $147,360 - $235,438	56,460 New	56,460 $189,000
Q2 2021 Mar 30, 2023	BUY	$2.61 - $4.17 $8,803 - $14,065	3,373 Added 6.35%	56,460 $189,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $147,222 - $235,217	56,407 Added 106428.3%	56,460 $189,000
Q1 2021 Jun 26, 2023	BUY	$2.91 - $4.32 $154,483 - $229,335	53,087 New	53,087 $165 Million
Q1 2021 Mar 30, 2023	BUY	$2.91 - $4.32 $7,769 - $11,534	2,670 Added 5.3%	53,087 $165,000
Q1 2021 May 14, 2021	SELL	$2.91 - $4.32 $146,559 - $217,572	-50,364 Reduced 99.89%	53 $165,000
Q4 2020 Jun 22, 2023	BUY	$2.15 - $3.5 $108,396 - $176,459	50,417 New	50,417 $138,000
Q4 2020 Mar 30, 2023	BUY	$2.15 - $3.5 $1,913 - $3,115	890 Added 1.8%	50,417 $138,000
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $1,913 - $3,115	890 Added 1.8%	50,417 $139,000
Q3 2020 Jun 26, 2023	BUY	$2.77 - $6.17 $137,189 - $305,581	49,527 New	49,527 $141,000
Q3 2020 Mar 30, 2023	SELL	$2.77 - $6.17 $12,850 - $28,622	-4,639 Reduced 8.56%	49,527 $141,000
Q3 2020 Nov 13, 2020	SELL	$2.77 - $6.17 $12,850 - $28,622	-4,639 Reduced 8.56%	49,527 $142,000
Q2 2020 Jun 26, 2023	BUY	$0.87 - $3.13 $47,124 - $169,539	54,166 New	54,166 $167,000
Q2 2020 Mar 30, 2023	BUY	$0.87 - $3.13 $47,124 - $169,539	54,166 New	54,166 $167,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $47,124 - $169,539	54,166 New	54,166 $168,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account